Tempest Therapeutics (TPST)
(Delayed Data from NSDQ)
$2.19 USD
+0.02 (0.92%)
Updated Jun 28, 2024 04:00 PM ET
After-Market: $2.18 -0.01 (-0.46%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/8/24 |
---|---|
Current Quarter | -0.47 |
EPS Last Quarter | -0.36 |
Last EPS Surprise | 18.18% |
ABR | 1.00 |
Earnings ESP
|
-19.15% |
---|---|
Current Year | -1.57 |
Next Year | -1.64 |
EPS (TTM) | -1.72 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.47 | -0.45 | -1.57 | -1.64 |
# of Estimates | 4 | 4 | 4 | 5 |
Most Recent Consensus | -0.56 | -0.45 | NA | -2.61 |
High Estimate | -0.37 | -0.36 | -1.17 | -0.64 |
Low Estimate | -0.57 | -0.60 | -2.07 | -2.61 |
Year ago EPS | -0.54 | -0.48 | -1.91 | -1.57 |
Year over Year Growth Est. | 12.96% | 6.25% | 17.80% | -4.49% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 1 |
Up Last 30 Days | 0 | 0 | 0 | 1 |
Up Last 60 Days | 1 | 0 | 0 | 2 |
Down Last 7 Days | 0 | 0 | 1 | 0 |
Down Last 30 Days | 1 | 1 | 1 | 1 |
Down Last 60 Days | 2 | 2 | 2 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.47 | -0.45 | -1.57 | -1.64 |
7 Days Ago | -0.47 | -0.45 | -1.51 | -1.64 |
30 Days Ago | -0.46 | -0.45 | -1.51 | -1.63 |
60 Days Ago | -0.45 | -0.44 | -1.51 | -1.64 |
90 Days Ago | -0.45 | -0.44 | -1.51 | -1.64 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.56 | -0.45 | -1.17 | -1.63 |
Zacks Consensus Estimate | -0.47 | -0.45 | -1.57 | -1.64 |
Earnings ESP | -19.15% | 0.00% | 25.36% | 0.79% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.36 | -0.34 | -0.48 | -0.54 | NA |
Estimate | -0.44 | -0.38 | -0.55 | -0.58 | NA |
Difference | 0.08 | 0.04 | 0.07 | 0.04 | 0.06 |
Surprise | 18.18% | 10.53% | 12.73% | 6.90% | 12.09% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more